Title | Type | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) | %Female (2018) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Alimentary Pharmacology and Therapeutics | journal | 3.827 Q1 | 207 | 542 | 1313 | 14086 | 5672 | 652 | 4.08 | 25.99 | 37.53 | |
2 | npj Breast Cancer | journal | 2.916 Q1 | 46 | 39 | 88 | 1392 | 442 | 84 | 5.45 | 35.69 | 45.38 | |
3 | npj Vaccines | journal | 2.527 Q1 | 47 | 51 | 50 | 2652 | 236 | 48 | 4.72 | 52.00 | 42.75 | |
4 | Journal of Antimicrobial Chemotherapy | journal | 2.139 Q1 | 221 | 569 | 1517 | 18751 | 6676 | 1291 | 4.38 | 32.95 | 47.83 | |
5 | Rheumatology | journal | 2.089 Q1 | 198 | 439 | 1030 | 11146 | 3958 | 777 | 3.66 | 25.39 | 45.13 | |
6 | International Journal of Neuropsychopharmacology | journal | 1.846 Q1 | 125 | 138 | 406 | 7958 | 1857 | 395 | 4.21 | 57.67 | 39.33 | |
7 | European Heart Journal - Cardiovascular Pharmacotherapy | journal | 1.779 Q1 | 40 | 46 | 134 | 1030 | 387 | 82 | 3.62 | 22.39 | 18.04 | |
8 | Molecular Therapy - Oncolytics | journal | 1.753 Q1 | 42 | 29 | 94 | 1314 | 488 | 93 | 5.79 | 45.31 | 42.06 | |
9 | HIV Medicine | journal | 1.697 Q1 | 86 | 121 | 289 | 3373 | 852 | 265 | 3.37 | 27.88 | 49.14 | |
10 | Antimicrobial Resistance and Infection Control | journal | 1.681 Q1 | 66 | 155 | 238 | 5364 | 865 | 229 | 3.47 | 34.61 | 47.57 | |
11 | Journal of Psychopharmacology | journal | 1.672 Q1 | 135 | 138 | 426 | 8170 | 1978 | 401 | 4.03 | 59.20 | 41.74 | |
12 | Journal of Biomedical Science | journal | 1.611 Q1 | 110 | 90 | 283 | 6998 | 1398 | 283 | 5.40 | 77.76 | 42.55 | |
13 | Cochrane Database of Systematic Reviews | journal | 1.609 Q1 | 327 | 1109 | 4456 | 109105 | 17077 | 4430 | 3.51 | 98.38 | 48.02 | |
14 | BioDrugs | journal | 1.601 Q1 | 79 | 60 | 128 | 3632 | 663 | 124 | 5.11 | 60.53 | 36.27 | |
15 | Orphanet Journal of Rare Diseases | journal | 1.589 Q1 | 136 | 225 | 519 | 8994 | 2296 | 513 | 3.99 | 39.97 | 54.33 | |
16 | CNS Drugs | journal | 1.553 Q1 | 129 | 90 | 251 | 6083 | 1204 | 247 | 4.41 | 67.59 | 40.57 | |
17 | British Journal of Clinical Pharmacology | journal | 1.530 Q1 | 167 | 315 | 866 | 11637 | 3241 | 741 | 3.51 | 36.94 | 40.11 | |
18 | Clinical Pharmacokinetics | journal | 1.529 Q1 | 184 | 119 | 340 | 6974 | 1545 | 311 | 4.47 | 58.61 | 35.37 | |
19 | Drugs | journal | 1.527 Q1 | 188 | 161 | 480 | 11332 | 2556 | 471 | 5.41 | 70.39 | 36.91 | |
20 | Pharmacoepidemiology and Drug Safety | journal | 1.519 Q1 | 109 | 185 | 560 | 5306 | 1461 | 510 | 2.49 | 28.68 | 48.62 | |
21 | Drug Safety | journal | 1.438 Q1 | 140 | 132 | 324 | 4868 | 1211 | 273 | 3.30 | 36.88 | 47.67 | |
22 | Trials | journal | 1.287 Q1 | 98 | 690 | 1785 | 27506 | 4060 | 1740 | 2.04 | 39.86 | 47.54 | |
23 | Acta Pharmacologica Sinica | journal | 1.224 Q1 | 117 | 189 | 460 | 10647 | 1838 | 454 | 3.81 | 56.33 | 41.59 | |
24 | AIDS Research and Therapy | journal | 1.143 Q1 | 49 | 28 | 145 | 1072 | 337 | 143 | 2.38 | 38.29 | 43.91 | |
25 | Therapeutic Advances in Drug Safety | journal | 1.131 Q1 | 46 | 61 | 85 | 2938 | 247 | 59 | 2.76 | 48.16 | 44.35 | |
26 | Drugs and Aging | journal | 1.128 Q1 | 109 | 94 | 273 | 5367 | 871 | 266 | 2.92 | 57.10 | 43.10 | |
27 | CNS Neuroscience and Therapeutics | journal | 1.122 Q1 | 91 | 137 | 352 | 7603 | 1071 | 290 | 3.00 | 55.50 | 46.80 | |
28 | Expert Opinion on Investigational Drugs | journal | 1.076 Q1 | 117 | 94 | 395 | 7440 | 1303 | 376 | 3.61 | 79.15 | 37.26 | |
29 | Expert Review of Neurotherapeutics | journal | 1.064 Q1 | 98 | 92 | 369 | 7652 | 1176 | 325 | 3.10 | 83.17 | 31.97 | |
30 | Therapeutic Advances in Respiratory Disease | journal | 1.020 Q2 | 50 | 38 | 118 | 2248 | 373 | 113 | 3.34 | 59.16 | 45.35 | |
31 | Expert Opinion on Drug Safety | journal | 1.007 Q2 | 90 | 131 | 484 | 7888 | 1613 | 465 | 3.34 | 60.21 | 45.54 | |
32 | Expert Opinion on Emerging Drugs | journal | 0.977 Q2 | 54 | 29 | 116 | 2879 | 361 | 108 | 3.05 | 99.28 | 32.58 | |
33 | Antiviral Therapy | journal | 0.931 Q2 | 93 | 94 | 293 | 2958 | 586 | 285 | 2.03 | 31.47 | 42.88 | |
34 | American Journal of Cardiovascular Drugs | journal | 0.903 Q2 | 60 | 50 | 135 | 2327 | 308 | 127 | 2.40 | 46.54 | 29.70 | |
35 | HIV Clinical Trials | journal | 0.899 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
36 | Expert Review of Anticancer Therapy | journal | 0.881 Q2 | 85 | 127 | 391 | 9577 | 886 | 353 | 2.39 | 75.41 | 35.84 | |
37 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.877 Q2 | 57 | 59 | 183 | 2788 | 424 | 176 | 2.33 | 47.25 | 37.04 | |
38 | BMC pharmacology & toxicology | journal | 0.870 Q2 | 43 | 87 | 185 | 3087 | 467 | 184 | 2.32 | 35.48 | 39.29 | |
39 | Pharmaceutical Statistics | journal | 0.868 Q2 | 46 | 64 | 151 | 1793 | 187 | 146 | 1.45 | 28.02 | 28.29 | |
40 | Expert Opinion on Pharmacotherapy | journal | 0.866 Q2 | 93 | 213 | 696 | 15010 | 2012 | 652 | 2.80 | 70.47 | 34.87 | |
41 | International Journal of STD and AIDS | journal | 0.821 Q2 | 78 | 216 | 599 | 5584 | 875 | 562 | 1.46 | 25.85 | 48.22 | |
42 | Cardiovascular Therapeutics | journal | 0.780 Q2 | 54 | 63 | 179 | 2156 | 407 | 176 | 2.22 | 34.22 | 36.14 | |
43 | Clinical Drug Investigation | journal | 0.731 Q2 | 67 | 121 | 314 | 4102 | 686 | 302 | 2.29 | 33.90 | 38.67 | |
44 | Expert Review of Clinical Pharmacology | journal | 0.731 Q2 | 60 | 119 | 341 | 9352 | 901 | 316 | 2.53 | 78.59 | 35.77 | |
45 | Fundamental and Clinical Pharmacology | journal | 0.712 Q2 | 85 | 72 | 197 | 3009 | 464 | 196 | 2.20 | 41.79 | 49.07 | |
46 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.710 Q2 | 61 | 69 | 252 | 3294 | 416 | 238 | 1.71 | 47.74 | 36.59 | |
47 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.710 Q2 | 81 | 146 | 375 | 4025 | 813 | 359 | 2.24 | 27.57 | 42.91 | |
48 | Human Psychopharmacology | journal | 0.657 Q2 | 86 | 33 | 167 | 1254 | 417 | 164 | 2.28 | 38.00 | 38.99 | |
49 | Journal of Oncology Pharmacy Practice | journal | 0.630 Q2 | 44 | 101 | 262 | 1997 | 380 | 250 | 1.54 | 19.77 | 49.45 | |
50 | Paediatric Drugs | journal | 0.620 Q2 | 70 | 54 | 152 | 3443 | 323 | 145 | 1.87 | 63.76 | 47.56 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®